Press Releases

GlobeNewswire, Inc.

Complete SAFE KIDNEY II data confirm sustained reduction in viral load and resolution of biopsy-proven BKPyV-associated nephropathy with continued antiviral effect to 38 weeks Systematic literature review demonstrates the association between...

U.S. Department of the Treasury

Good afternoon.

GlobeNewswire, Inc.

Zurich, June 17, 2026 (GLOBE NEWSWIRE) -- The technologies now driving the global economy, from advanced computing to artificial intelligence and robotics, are built patiently, over decades of sustained investment and deep scientific groundwork....

GlobeNewswire, Inc.

SANTA ANA, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic...

GlobeNewswire, Inc.

ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals,...

GlobeNewswire, Inc.

Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, June 17, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative...

GlobeNewswire, Inc.

ZURICH, SWITZERLAND – June 18, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced that the Company has generated new in vitro proof-of-concept data validating its novel...

MENAFN

(MENAFN) Switzerland is voting on Sunday in a referendum over a controversial proposal that would limit the country’s population to 10 million, a move that has intensified debate over immigration and national resources.

EIN Presswire

InteligênciaArtificial.com is a premium domain name asset targeting more than 260 million Portuguese speakers worldwide, with Brazil as its primary market.

GlobeNewswire, Inc.

Geneva, Switzerland, June 18, 2026 (GLOBE NEWSWIRE) -- EPO-Granted Patent Embeds NFTs Directly into Secure Semiconductors, Creating an Immutable Chain of Provenance, Ownership, and Authenticity for WISe.ART’s Global Art Ecosystem SEALSQ Corp...

GlobeNewswire, Inc.

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...

GlobeNewswire, Inc.

Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes Accelerated approval in children aged eight to 17 years old recently diagnosed with stage 3 T1D to delay the...

EIN Presswire

64K Cellssense highlights its Swiss research, manufacturing context and European wellness network as beauty-from-within grows in China.

GlobeNewswire, Inc.

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease Grant supports extension of Part 1 of Phase 2 VacSYn trial of ACI-7104 Planned extension of Part 1 will assess long-term safety and efficacy...

GlobeNewswire, Inc.

WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology EPO-Granted Patent Embeds NFTs Directly into Secure Semiconductors,...

GlobeNewswire, Inc.

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in...

EIN Presswire

TOKYO, JAPAN, June 11, 2026 /⁨EINPresswire.com⁩/ -- LOTTE HOLDINGDS, CO., LTD. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE HOLDINGDS”) announces an investment in ClearideBio Therapeutics AG (hereinafter, “ClearideBio”), an...

GlobeNewswire, Inc.

Tokyo, Japan and Cambridge, UK, 10 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that it has joined OpenFold, a non-profit AI research consortium that promotes the development of open-source AI software tools for biology...

EIN Presswire

RIEHEN, BASEL, SWITZERLAND, June 9, 2026 /⁨EINPresswire.com⁩/ -- MetaShape Pharma AG (“MetaShape” or the “Company”), a biopharmaceutical company developing MS 001, a first-in-class oral small-molecule drug designed to amplify GLP-1 therapies,...

EIN Presswire

Innovative Swiss security technology against global cyber threats.